Report Detail
Global (United States, European Union and China) Ioversol Market Research Report 2019-2025
- RnM3685576 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Chemical & Material
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
In 2019, the market size of Ioversol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ioversol.
This report studies the global market size of Ioversol, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ioversol production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Market Segment by Product Type
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Market Segment by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Ioversol status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ioversol manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Ioversol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Ioversol Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Ioversol 34% Injectable Solution (Optiray 160)
- 1.3.3 Ioversol 51% Injectable Solution (Optiray 240)
- 1.3.4 Ioversol 64% Injectable Solution (Optiray 300)
- 1.3.5 Ioversol 68% Injectable Solution (Optiray 320)
- 1.3.6 Ioversol 74% Injectable Solution (Optiray 350)
- 1.4 Market Segment by Application
- 1.4.1 Global Ioversol Market Share by Application (2019-2025)
- 1.4.2 X-ray
- 1.4.3 CT Scan
- 1.4.4 Brain Disorders
- 1.4.5 Blood Vessel Disorders
- 1.4.6 Heart Disorders
- 1.4.7 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Ioversol Production Value 2014-2025
- 2.1.2 Global Ioversol Production 2014-2025
- 2.1.3 Global Ioversol Capacity 2014-2025
- 2.1.4 Global Ioversol Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Ioversol Market Size CAGR of Key Regions
- 2.2.2 Global Ioversol Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Ioversol Capacity by Manufacturers
- 3.1.2 Global Ioversol Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Ioversol Revenue by Manufacturers (2014-2019)
- 3.2.2 Ioversol Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Ioversol Market Concentration Ratio (CR5 and HHI)
- 3.3 Ioversol Price by Manufacturers
- 3.4 Key Manufacturers Ioversol Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Ioversol Market
- 3.6 Key Manufacturers Ioversol Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Ioversol 34% Injectable Solution (Optiray 160) Production and Production Value (2014-2019)
- 4.1.2 Ioversol 51% Injectable Solution (Optiray 240) Production and Production Value (2014-2019)
- 4.1.3 Ioversol 64% Injectable Solution (Optiray 300) Production and Production Value (2014-2019)
- 4.1.4 Ioversol 68% Injectable Solution (Optiray 320) Production and Production Value (2014-2019)
- 4.1.5 Ioversol 74% Injectable Solution (Optiray 350) Production and Production Value (2014-2019)
- 4.2 Global Ioversol Production Market Share by Type
- 4.3 Global Ioversol Production Value Market Share by Type
- 4.4 Ioversol Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Ioversol Consumption by Application
6 Production by Regions
- 6.1 Global Ioversol Production (History Data) by Regions 2014-2019
- 6.2 Global Ioversol Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Ioversol Production Growth Rate 2014-2019
- 6.3.2 United States Ioversol Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Ioversol Import & Export
- 6.4 European Union
- 6.4.1 European Union Ioversol Production Growth Rate 2014-2019
- 6.4.2 European Union Ioversol Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Ioversol Import & Export
- 6.5 China
- 6.5.1 China Ioversol Production Growth Rate 2014-2019
- 6.5.2 China Ioversol Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Ioversol Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Ioversol Consumption by Regions
- 7.1 Global Ioversol Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Ioversol Consumption by Type
- 7.2.2 United States Ioversol Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Ioversol Consumption by Type
- 7.3.2 European Union Ioversol Consumption by Application
- 7.4 China
- 7.4.1 China Ioversol Consumption by Type
- 7.4.2 China Ioversol Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Ioversol Consumption by Type
- 7.5.2 Rest of World Ioversol Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Liebel-Flarsheim Company LLC
- 8.1.1 Liebel-Flarsheim Company LLC Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Ioversol
- 8.1.4 Ioversol Product Introduction
- 8.1.5 Liebel-Flarsheim Company LLC Recent Development
- 8.2 Guerbet
- 8.2.1 Guerbet Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Ioversol
- 8.2.4 Ioversol Product Introduction
- 8.2.5 Guerbet Recent Development
- 8.3 Jiangsu Hengrui Medicine Co
- 8.3.1 Jiangsu Hengrui Medicine Co Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Ioversol
- 8.3.4 Ioversol Product Introduction
- 8.3.5 Jiangsu Hengrui Medicine Co Recent Development
- 8.4 Mallinckrodt Pharmaceuticals
- 8.4.1 Mallinckrodt Pharmaceuticals Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Ioversol
- 8.4.4 Ioversol Product Introduction
- 8.4.5 Mallinckrodt Pharmaceuticals Recent Development
- 8.5 Ultraject
- 8.5.1 Ultraject Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Ioversol
- 8.5.4 Ioversol Product Introduction
- 8.5.5 Ultraject Recent Development
- 8.6 China Resources Pharmaceutical (Shanghai) Co
- 8.6.1 China Resources Pharmaceutical (Shanghai) Co Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Ioversol
- 8.6.4 Ioversol Product Introduction
- 8.6.5 China Resources Pharmaceutical (Shanghai) Co Recent Development
- 8.7 HB Ocean
- 8.7.1 HB Ocean Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Ioversol
- 8.7.4 Ioversol Product Introduction
- 8.7.5 HB Ocean Recent Development
- 8.8 Novalek Pharmaceuticals Pvt. Ltd
- 8.8.1 Novalek Pharmaceuticals Pvt. Ltd Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Ioversol
- 8.8.4 Ioversol Product Introduction
- 8.8.5 Novalek Pharmaceuticals Pvt. Ltd Recent Development
- 8.9 Stellence Pharmscience Pvt. Ltd
- 8.9.1 Stellence Pharmscience Pvt. Ltd Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Ioversol
- 8.9.4 Ioversol Product Introduction
- 8.9.5 Stellence Pharmscience Pvt. Ltd Recent Development
- 8.10 A.S. Joshi & Company
- 8.10.1 A.S. Joshi & Company Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Ioversol
- 8.10.4 Ioversol Product Introduction
- 8.10.5 A.S. Joshi & Company Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Ioversol Capacity, Production Forecast 2019-2025
- 9.1.2 Global Ioversol Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Ioversol Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Ioversol Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Ioversol Production Forecast by Type
- 9.7.2 Global Ioversol Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Ioversol Sales Channels
- 10.2.2 Ioversol Distributors
- 10.3 Ioversol Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Ioversol. Industry analysis & Market Report on Ioversol is a syndicated market report, published as Global (United States, European Union and China) Ioversol Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Ioversol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
